Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can daily home monitoring keep heart failure patients out of the hospital?

NCT ID NCT07680634

Disease control Sponsor: St. Antonius Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study looks at whether a hybrid care pathway that includes home telemonitoring helps people with heart failure spend more days at home and out of the hospital. Participants measure their weight, blood pressure, heart rate, and symptoms daily, sending the data to a medical center that can intervene early. Researchers will compare outcomes for patients in the program with those receiving usual care across seven hospitals in the Netherlands. The goal is to see if this approach improves survival, quality of life, and medication use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
hybrid heart failure care pathway with home telemonitoring
What this could lead to
If it works, this approach could help heart failure patients stay healthier at home and reduce hospital visits, potentially becoming a standard care model.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by patient selection. The telemonitoring program requires digital literacy, which may limit who can benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 6,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2023

Expected to finish

Jun 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The entire HF population treated at the participating hospitals will be included in the analysis, except for those patients who have formally objected to the use of their data for scientific research

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (at least 18 years or older) * Diagnosed with heart failure according the prevailling ESC guideline * Treatment at the outpatient clinic at one of the seven participating hospitals * Sufficient digital literacy and adequate Dutch language proficiency by the patient or throught the informal caregiver. Exclusion Criteria: * Inability or unwillingness to participate in home telemonitoring * Patients with end-stage heart failure or other terminal conditions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart failure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart failure

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Canisius-Wilhelmina Hospital

    RECRUITING

    Nijmegen, Utrecht, 3435CM, Netherlands

  • Catharina Hospital

    RECRUITING

    Eindhoven, Utrecht, 3435CM, Netherlands

  • Maasstad Hospital

    RECRUITING

    Rotterdam, Utrecht, 3435CM, Netherlands

  • Martini Hospital

    RECRUITING

    Groningen, Utrecht, 3435CM, Netherlands

  • Medisch Spectrum Twente

    RECRUITING

    Enschede, Utrecht, 3435CM, Netherlands

  • OLVG

    RECRUITING

    Amsterdam, Utrecht, 3435CM, Netherlands

  • St. Antonius Hospital

    RECRUITING

    Nieuwegein, Utrecht, 3435CM, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.